Evolus, Inc. Common Stock (EOLS): Valuation
TTM figures as of June 30, 2026
Evolus, Inc. Common Stock trades at a -3.53% free-cash-flow yield. That FCF yield is higher than 78% of its own month-end history back to 2018.
Earnings yield -6.63%. ROIC -18.3%. Piotroski F-score 4 of 9. Net debt $111.6M.
103 month-end valuation observations are on file, starting February 2018.
Sector comparison uses 2682 Healthcare names.
Frequently asked questions
Is EOLS cheap versus its own history?
Evolus, Inc. Common Stock trades at a -3.53% free-cash-flow yield. That FCF yield is higher than 78% of its own month-end history back to 2018.
What is EOLS's free-cash-flow yield?
Evolus, Inc. Common Stock currently yields -3.53% of market cap as trailing free cash flow.
Where do these valuation figures come from?
Yields and quality metrics are computed from the same SEC TTM figures as the financials page, against the live market cap. Historical bands reconstruct month-end market cap from split-adjusted closes and the share count in the units it was filed, then divide by those dollar totals. Nothing here is a third-party estimate.